Sensitivity and specificity of executive function tests for Alzheimer's disease

被引:15
|
作者
Huang, Shu-Fen [1 ]
Liu, Ching-Kuan [2 ]
Chang, Chiung-Chih [3 ]
Su, Chwen-Yng [4 ]
机构
[1] Pingtung Hosp, Dept Rehabil Med, Minist Hlth & Welf, Pingtung, Taiwan
[2] Kaohsiung Med Univ, Dept Neurol, Kaohsiung, Taiwan
[3] Kaohsiung Chang Gung Mem Hosp, Dept Neurol, Kaohsiung, Taiwan
[4] Kaohsiung Med Univ, Occupat Therapy, Kaohsiung, Taiwan
关键词
Aging; assessment/diagnosis; cognition; MILD COGNITIVE IMPAIRMENT; VERBAL FLUENCY; FUNCTION DEFICITS; PROCESSING-SPEED; TEST-PERFORMANCE; DIAGNOSTIC-TEST; DEMENTIA; MEMORY; DYSFUNCTION; ATROPHY;
D O I
10.1080/23279095.2016.1204301
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Decline in executive function (EF) occurs early in Alzheimer's disease (AD) and can interfere with daily functioning. Unfortunately, little is known about the relative ability of traditional EF tests to detect these cognitive changes. Given that timely diagnosis and intervention are essential to improving functional outcome in this population, our aim was to identify the specific EF measures that best differentiated mild dementia from normal aging. Thirty-one patients with mild AD and 31 controls were administered 7 EF tests. Findings indicated significant between-group differences on all measures except Wisconsin Card Sorting Test. The remaining 6 tests displayed fair to good accuracy discriminating between AD cases and controls. Only category fluency and Tower of London test remained in the final regression model that yielded the highest AUC of 0.90, which was not statistically different from that of either test alone. Overall, most of the tests employed were valid for assessing mild EF disturbances. Specifically, the two measures can be used in isolation for quick screening or in combination to facilitate a more in-depth evaluation of EF performance. This study contributes to clinical field by testifying to the validity of various EF tests to identify AD-related compromises in this cognitive domain.
引用
收藏
页码:493 / 504
页数:12
相关论文
共 50 条
  • [31] The sensitivity and specificity of a brief test of semantic interference in MCI and mild Alzheimer's disease
    Loewenstein, D
    Acevedo, A
    Agron, J
    Duara, R
    NEUROBIOLOGY OF AGING, 2004, 25 : S133 - S133
  • [32] Executive control processes in Alzheimer's disease
    Rosario Garcia-Viedma, Ma
    Fernandez-Guinea, Sara
    Martos-Montes, Rafael
    ANALES DE PSICOLOGIA, 2012, 28 (03): : 1021 - 1032
  • [33] Executive dysfunction in early Alzheimer's disease
    Binetti, G
    Magni, E
    Padovani, A
    Cappa, SF
    Bianchetti, A
    Trabucchi, M
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1996, 60 (01): : 91 - 93
  • [34] COMPARATIVE SENSITIVITY AND SPECIFICITY OF NONINVASIVE PANCREATIC FUNCTION-TESTS
    CAMPBELL, D
    SLAFF, J
    CURINGTON, C
    CONNERY, K
    TOSKES, P
    GASTROENTEROLOGY, 1985, 88 (05) : 1341 - 1341
  • [35] COMPARATIVE SENSITIVITY AND SPECIFICITY OF NONINVASIVE PANCREATIC FUNCTION-TESTS
    CAMPBELL, D
    SLAFF, J
    CURINGTON, C
    CONNERY, K
    TOSKES, P
    DIGESTIVE DISEASES AND SCIENCES, 1984, 29 (10) : 944 - 944
  • [36] Cholinesterase inhibitors selectively benefit attention and executive function in Alzheimer's disease (AD)
    Behl, P.
    Black, S.
    Lanctot, K.
    Streiner, D.
    BRAIN AND COGNITION, 2006, 62 (01) : 85 - 85
  • [37] PERFORMANCE OF HEALTHY ELDERLY WITH ALZHEIMER'S DISEASE AT AN EARLY STAGE IN EXECUTIVE FUNCTION AND LANGUAGE
    Santos, M. T.
    Couto, G. C.
    Achieri, J. C.
    Junior, C. A.
    EUROPEAN PSYCHIATRY, 2011, 26
  • [38] Executive function and functional impairment in Alzheimer's disease and fronto-temporal dementia
    Nadkarni, NK
    Black, SE
    NEUROBIOLOGY OF AGING, 2004, 25 : S114 - S114
  • [39] Influence of executive function on locomotor function: Divided attention increases gait variability in Alzheimer's disease
    Sheridan, PL
    Solomont, J
    Kowall, N
    Hausdorff, JM
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2003, 51 (11) : 1633 - 1637
  • [40] Neuropsychological tests in Alzheimer’s disease
    F. Boller
    G. Dalla Barba
    Aging Clinical and Experimental Research, 2001, 13 : 210 - 220